Holen Sie sich die Stockscreener-App
4.82
2.77%
0.13
Handel nachbörslich:
4.81
-0.01
-0.21%
Schlusskurs vom Vortag:
$4.69
Offen:
$4.63
24-Stunden-Volumen:
5.01M
Relative Volume:
1.21
Marktkapitalisierung:
$1.14B
Einnahmen:
$251.85M
Nettoeinkommen (Verlust:
$-72.58M
KGV:
-40.17
EPS:
-0.12
Netto-Cashflow:
$-63.80M
1W Leistung:
-7.66%
1M Leistung:
-2.03%
6M Leistung:
-18.17%
1J Leistung:
-18.86%
1-Tages-Spanne:
$4.58
$4.96
1-Wochen-Bereich:
$4.32
$5.4695
52-Wochen-Spanne:
$4.32
$10.13
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Vergleichen Sie ARDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
4.82 | 1.14B | 251.85M | -72.58M | -63.80M | -0.3134 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
| 2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-23 | Eingeleitet | Wedbush | Outperform |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Fortgesetzt | Citigroup | Buy |
| 2020-02-18 | Fortgesetzt | Jefferies | Buy |
| 2020-02-12 | Eingeleitet | Citigroup | Buy |
| 2020-02-10 | Eingeleitet | Cowen | Outperform |
| 2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-24 | Eingeleitet | Jefferies | Buy |
| 2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-29 | Bestätigt | Citigroup | Buy |
| 2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
| 2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary (NASDAQ:ARDX) - Seeking Alpha
Ardelyx stock hits 52-week low at $4.34 amid market challenges - Investing.com Canada
Ardelyx (NASDAQ:ARDX) Sets New 1-Year LowShould You Sell? - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Down 6.5%Here's What Happened - MarketBeat
State Street Corp Acquires 176,789 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near? - Yahoo Finance
Ardelyx (ARDX) Sees Its Depressed Stock Turning Around - TipRanks
Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - The Eastern Progress Online
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - The Eastern Progress Online
Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineARDX - The Eastern Progress Online
ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Ardelyx, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Ardelyx, Inc - The Eastern Progress Online
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - The Eastern Progress Online
Ardelyx CEO Michael Raab sells $131,620 in stock By Investing.com - Investing.com South Africa
Ardelyx CEO Michael Raab sells $131,620 in stock - Investing.com India
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - The Eastern Progress Online
Faruqi & Faruqi Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - The Eastern Progress Online
Objective long/short (ARDX) Report - Stock Traders Daily
Hyperphosphatemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Ardelyx, Shield Therapeutics, Kyowa Kirin Co., Ltd., Shanghai Alebund Pharma, Sanofi, Bayer, Keryx - The Globe and Mail
Ardelyx, Inc. (NASDAQ:ARDX): Are Analysts Optimistic? - Simply Wall St
BNP Paribas Financial Markets Boosts Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCXM - The Eastern Progress Online
Ardelyx FY2027 EPS Estimate Increased by Leerink Partnrs - MarketBeat
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - The Eastern Progress Online
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ardelyx Inc-Aktie (ARDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Dec 10 '24 |
Sale |
5.26 |
25,000 |
131,620 |
1,150,385 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):